Cellular Biomedicine Group Stock Forecast for 2023 - 2025 - 2030

Updated on 02/05/2023

Stock Rating
2
Price Target
$0.00
Consensus
-
Upside
0.00%
Analysts
0
Stock Rating
2
Upside
0.00%
Analysts
0
Price Target
$0.00

Cellular Biomedicine Group Stock Forecast and Price Target

The average target price for Cellular Biomedicine Group's stock set by renowned analysts in recent months is $0.00, representing a potential upside of approximately 100% from its last closing price if met by 2024. This estimation is based on a high estimate of $0.00 and a low estimate of $0.00.

$0.00

0.00% Upside

-

Cellular Biomedicine Group Fair Value Forecast for 2023 - 2025 - 2030

Cellular Biomedicine Group Revenue Forecast for 2023 - 2025 - 2030

Cellular Biomedicine Group Dividend per Share Forecast for 2023 - 2025 - 2030

Cellular Biomedicine Group Free Cash Flow Forecast for 2023 - 2025 - 2030

Cellular Biomedicine Group Net Income Forecast for 2023 - 2025 - 2030

Cellular Biomedicine Group EBITDA Forecast for 2023 - 2025 - 2030

Cellular Biomedicine Group EBIT Forecast for 2023 - 2025 - 2030

Cellular Biomedicine Group EPS Price Prediction Forecast for 2023 - 2025 - 2030